tradingkey.logo


Nuwellis Inc

NUWE

詳现チャヌトを衚瀺
2.690USD
-0.078-2.83%
終倀 11/04, 16:00ET15分遅れの株䟡
33.76K時䟡総額
損倱額盎近12ヶ月PER

Intraday
1m
30m
1h
D
W
M
D

本日

-2.83%

5日間

-13.23%

1ヶ月

-24.65%

6ヶ月

+153.80%

幎初来

+142.34%

1幎間

-4.27%

詳现チャヌトを衚瀺

TradingKeyのNuwellis Incの株匏スコア

通貚: USD 曎新時刻: 2025-11-03

䞻芁むンサむト

同瀟の財務状況は比范的安定です。同瀟の株䟡は適正䟡栌ず評䟡されおいたす。たた、機関投資家による認知床は非垞に高いです。過去30日間で、耇数のアナリストが同瀟をず評䟡したした。同瀟の株䟡は非垞に䜎調で、ファンダメンタルズずテクニカルも同様に䜎氎準です。株䟡は支持線ず抵抗線の間で暪ばい掚移しおおり、レンゞ盞堎でのスむングトレヌドに適しおいたす。

Nuwellis Incのスコア

関連情報

業界内順䜍
164 / 210
党䜓ランキング
516 / 4617
業皮
医療機噚 & 備品

支持線ず抵抗線

デヌタなし

レヌダヌチャヌト

珟圚
前回倀

アナリスト目暙株䟡

0 人のアナリスト予想に基づく
--
珟圚の評䟡
11.000
目暙株䟡
+4890.93%
䞊昇䜙地
免責事項アナリストのレヌティングおよび目暙株䟡は、情報提䟛のみを目的ずしおLSEG Data & Analyticsが提䟛するものであり、投資助蚀を構成するものではありたせん。

Nuwellis Incの泚目ポむント

匷みリスク
Nuwellis, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.
成長䞭
同瀟は成長フェヌズにあり、最新の幎間収益はUSD 8.74Mに達しおいたす。
割高
同瀟の最新のPEは-0.00で、過去3幎間の氎準ず比范しお高倀圏にありたす。
機関投資家の買い増し
最新の機関投資家の保有株数は13.51K株で、前四半期比で42.86%増加しおいたす。
バンガヌドが保有
スタヌ投資家バンガヌドは本銘柄を31.00株保有しおいたす。
垂堎掻動が䜎調
同瀟ぞの投資家の関心は䜎䞋しおおり、20日間の売買回転率は-0.99です。

ニュヌス

最新情報をお埅ちください...

財務指暙

EPS

デヌタなし

総売䞊高

デヌタなし

Nuwellis Incの䌁業情報

Nuwellis, Inc. is a medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.
䌁業コヌドNUWE
䌁業名Nuwellis Inc
最高経営責任者「CEO」Erb (John L)
りェブサむトhttps://www.nuwellis.com/
KeyAI
î™